SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US OTC > Biotechs >

China Dasheng Biotech (CDBT)

CDBT RSS Feed
Add CDBT Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 8/23/2017 1:08:10 PM - Followers: 13 - Board type: Free - Posts Today: 0

 

Company Overview:

The Company derives its revenues from the sale of products in the biological products and agents market. All revenues generated are from sales to customers in China. The Company has two majority-owned subsidiaries in China. It has 80% interest in Hainan Lüshen Biology Technology Co., Ltd. (“Lüshen”) located in HaiKou, Hainan Province, China. Lüshen engages in developing, manufacturing and marketing artificial microorganisms (“AM”), high-efficiency microorganism (“HM”) based biological bacterium blends, and biological preservatives. The Company also has a 60% interest in Yangling Elemiss Foods Co., Ltd. (“Elemiss”) located in City of Yangling, Shaanxi Province, China. Elemiss engages in developing, manufacturing and marketing artificial microorganism (“AM”) based biological bacterium blends, and Bulgarian lactobacillus live stock feed additives. The Company had two joint ventures for real estate projects in China to develop commercial and residential real estate in China. The Company’s ownership interests in the two ventures are 17.5% and 16.5%, respectively. As a result, the Company accounts for these two ventures based on cost method of accounting.

The Company has been formally approved by the local tax bureau for the favorable tax benefit enjoyed by the foreign invested company, which allows two-year tax exemption of income tax from January 20, 2008 through January 19, 2010, and three-year 50% tax reduction from January 20, 2010 to January 19, 2013.

Overall, the Company is still enjoying remarkable market demand for its products in a relatively stable domestic market environment. Management’s focus has been on cost control to reduce expenses and thereby to boost profit margin.

The table below shows a breakdown of net sales by products as a percentage of total revenue for the first three quarters on both fiscal 2008 and fiscal 2009:

    Net Sales and Percentage on 2008     Net Sales and Percentage on 2009  
Product Line                        
AM/HM Crop Additives $ 6,658,568     58.30%   $ 9,115,576     56.70%  
AM/HM Livestock Additives $ 4,237,270     37.10%   $ 5,723,368     35.60%  
FGW Preservatives $ 525,377     4.60%   $ 1,237,918     7.70%  
Total $ 11,421,215     100%   $ 16,076,862     100%  

 

Chairman & CEO:  Jinjun Qi

Jinjun Qi is the Chairman of China Da Sheng Biotechnology Co., director of Gansu DS-Biology Engineering Research Institute and President of Gansu DS-Biology Science and Technology Stock Co. DS Group is based in New York City and its headquarters are in Gansu Province, China. Mr. Qi is a well respected economist and agronomist who has made significant contributions to revitalizing China’s agricultural industry through science and technology. Currently DS is working on a project in the U.S. to convert soil to fertilizer. Under Mr. Qi’s leadership DS Group has received numerous awards inside China. In 2008, he received a “Certificate of Appreciation” from the U.S. Department of Commerce.

Mr. Qi received a B.S. in from Gansu Agricultural University, a graduate degree from the Business Administration College of Lanzhou University, and graduate degree in economics from Gansu Provincial Committee Party School and M.B.A degrees from Tsinghua University and Australia National University.

 

Link to latest 10-Q:  http://www.sec.gov/Archives/edgar/data/1393067/000120445909000874/dasheng10q.htm

 

Total revenue grew approximately 43% to $5.3 million in the third quarter of 2009, compared with $3.7 million in the prior year quarter; -- Gross margin improved by 50% to $2.6 million in the third quarter of 2009, compared with $1.8 million in the prior year quarter; -- Operating expenses, as a percentage of revenue, were reduced by over 900 basis points to 20.2% in the third quarter of 2009, compared to 29.9% in the prior year quarter; -- Income from operations increased by 140% to $1.6 million in the third quarter of 2009, compared to $0.7 million in the prior year quarter; -- Net income rose over 200% to $1.3 million in the third quarter of 2009, or $0.04 per diluted share, compared with $0.4 million, or $0.01 per share in the prior year quarter; -- $10.4 million of cash on the balance sheet as of the quarter end, March 31, 2009.

Company Website:  http://www.chinadashengbio.com/    Alternate site:  http://english.gsdsjt.com/index.html

Investor Relations:  CSIR Group, LLC  Website:  http://csirgroup.com/  Contact:  Christine Petraglia  Phone:  646-354-8886  E-mail:  christine@csirgroup.com

Current Valuation:  at the current PPS of .34, the ttm P/E is 1.7 (updated daily)

  

NEWS

The current agriculture policy is benefit to product & sale of our Company’s or  21/4/2009
The company established eight sales districts for market   21/4/2009
No pay cuts, no staff cuts, sales quantity increased steadily--- Dasheng Company  21/4/2009
SEC verified and approved company’s the second quarter audit report  21/4/2009
The tenth annual summit of growing China  21/4/2009

REPORTING

05/18/2009 8:39AM PRNUS China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results
05/14/2009 3:31PM EDGAR (10-Q) - Quarterly Report
02/19/2009 1:21PM EDGAR - Amended Quarterly Report (10-Q/A)
02/12/2009 12:06PM EDGAR (10-Q) - Quarterly Report
02/10/2009 8:00AM PRNUS China Dasheng Biotechnology Company (CDBT.OB) Pre-Announces Fiscal Year 2009 Second Quarter Earnings
SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
CDBT
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
PostSubject
#391   Picked the wrong one then , lol DaReal 08/23/17 01:08:10 PM
#390   Don't think it's Lifeflip. This CEO is from adijas 08/23/17 12:37:07 PM
#389   Could be adijas 08/23/17 12:04:47 PM
#388   Looks like he is merging one of the adijas 08/23/17 12:02:32 PM
#387   Means next step -> Name change DaReal 08/23/17 12:02:06 PM
#386   Yeas, he is. adijas 08/23/17 11:56:34 AM
#385   NEW Sole Officer: ERIC MITCHELL per NVSOS DaReal 08/23/17 11:49:57 AM
#384   It sure could. I'm watching this for months adijas 08/22/17 02:33:45 PM
#383   100K bid @.04 - we'll see what happens Quintessence 08/22/17 02:12:50 PM
#382   Form 15 Was filed and signed by Rhonda DaReal 08/22/17 10:21:25 AM
#381   I bought in back then, and added today. adijas 08/22/17 10:17:00 AM
#380   That Vol was due to the Form15 Filing DaReal 08/22/17 10:06:46 AM
#379   Yeah, waiting for a long time. Finally. Some adijas 08/22/17 09:46:55 AM
#378   Reinstatement (Revival) Filing hit the NVSOS DaReal 08/22/17 09:30:40 AM
#377   odd stock. a penny to $+ and back sahd3g 06/21/13 07:38:58 AM
#376   .05 low? What is going on with this sahd3g 01/09/13 01:53:11 PM
#375   .10 on the bid. $1.00 on the ask. sahd3g 01/09/13 10:21:28 AM
#374   I recall a few years ago getting into sahd3g 01/09/13 07:56:19 AM
#373   I have not looked at anything here but TOUCAN 01/08/13 04:46:12 PM
#372   Do you have any idea what that research sahd3g 01/08/13 04:42:05 PM
#371   nothing better then riding free shares haha TOUCAN 01/08/13 04:34:55 PM
#370   I swing traded it a couple times off sahd3g 01/08/13 04:31:49 PM
#369   12,000% gain and the bid is way higher sahd3g 01/08/13 04:29:28 PM
#368   what price did get in this at? TOUCAN 01/08/13 04:26:23 PM
#367   WTF is going on?? I like it!! Wish sahd3g 01/08/13 04:22:25 PM
#366   someone(s) got lucky to get .055s and .099s TOUCAN 01/08/13 04:06:50 PM
#365   CHinese stocks seem to be rebounding with a WakingBake 01/08/13 03:58:30 PM
#364   Wow, nice bids too WakingBake 01/08/13 03:56:24 PM
#363   Wow!!! What's the occasion? Up 358.33% today!! Ask pingbag 01/08/13 11:13:23 AM
#362   .32 now!!! Wow...classic micro china stock...very unpredictable and sahd3g 02/14/11 03:52:06 PM
#361   I'd love to know what's up with this BigOnChina 01/24/11 02:32:53 PM
#360   http://finance.yahoo.com/q?s=CDBT.PK new report about CDBT?? sahd3g 01/24/11 08:37:21 AM
#359   Somebody is willing to buy at the ask: Sibware 01/20/11 01:46:15 PM
#358   HUH VERY BAD WHAT I DID: Sibware 01/20/11 01:41:49 PM
#357   There is no Market Manipulation HA! HA! HA! Sibware 01/20/11 01:32:56 PM
#356   .27 is back on the ask...this stock just sahd3g 01/18/11 01:40:11 PM
#355   .27 on the ask. What is going on sahd3g 01/11/11 02:53:59 PM
#354   .14!! this stock is flying. on the CGS sahd3g 01/11/11 01:15:35 PM
#353   CDBT ask is .12, then .3399! Looks like sahd3g 01/06/11 10:54:31 AM
#352   no...I got into this one primarily on TA sahd3g 12/06/10 07:56:16 AM
#351   I don't suppose you have any contact information BigOnChina 12/06/10 07:45:29 AM
#350   my understanding was that there was some problem sahd3g 12/06/10 06:53:21 AM
#349   I haven't heard one peep from any shareholder BigOnChina 12/05/10 11:02:37 PM
#348   Every cheap share is being slowly gobbled up...thankfully sahd3g 12/05/10 09:38:57 PM
#347   anyone know what's going on here? BigOnChina 12/05/10 07:56:23 PM
#346   No sure...although all along there were allegedly CDBT sahd3g 11/10/10 09:44:41 AM
#345   I've been holding CDBT all the way down BigOnChina 11/10/10 09:35:04 AM
#344   Ha...that's what I've been wondering about for a sahd3g 11/06/10 06:39:52 PM
#343   Maybe the managers have been released from jail. barsell 11/06/10 06:27:03 PM
#342   Anyone know why CDBT is up so much %???? sahd3g 11/06/10 04:58:52 PM
PostSubject